Cyclopharm Limited (ASX: CYC)
Australia
· Delayed Price · Currency is AUD
2.120
-0.010 (-0.47%)
Jan 21, 2025, 4:10 PM AEST
Cyclopharm Revenue
Cyclopharm had revenue of 13.21M AUD in the half year ending June 30, 2024, with 15.73% growth. This brings the company's revenue in the last twelve months to 24.06M, down -19.10% year-over-year. In the year 2023, Cyclopharm had annual revenue of 27.14M with 9.19% growth.
Revenue (ttm)
24.06M
Revenue Growth
-19.10%
P/S Ratio
8.39
Revenue / Employee
276.50K
Employees
87
Market Cap
236.72M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 27.14M | 2.28M | 9.19% |
Dec 31, 2022 | 24.85M | 4.86M | 24.30% |
Dec 31, 2021 | 20.00M | 2.31M | 13.09% |
Dec 31, 2020 | 17.68M | 668.06K | 3.93% |
Dec 31, 2019 | 17.01M | 1.49M | 9.57% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 22.18B |
Pro Medicus | 161.50M |
Cochlear | 2.24B |
Sonic Healthcare | 8.97B |
Telix Pharmaceuticals | 645.68M |
Ramsay Health Care | 16.66B |
Ansell | 2.43B |
Sigma Healthcare | 3.48B |